These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19229709

  • 1. Health status and the spiral of decline.
    Jones PW.
    COPD; 2009 Feb; 6(1):59-63. PubMed ID: 19229709
    [Abstract] [Full Text] [Related]

  • 2. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA.
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic goals and outcome measurements in COPD patients].
    Morr H.
    Med Klin (Munich); 2006 Apr 15; 101(4):279-82. PubMed ID: 16607483
    [Abstract] [Full Text] [Related]

  • 4. [Methodology and clinical impact of studies on disease progression].
    García Río F.
    Arch Bronconeumol; 2008 Apr 15; 44 Suppl 2():29-38. PubMed ID: 19087841
    [Abstract] [Full Text] [Related]

  • 5. It's about time--directing our attention toward modifying the course of COPD.
    Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard S.
    Respir Med; 2008 Jun 15; 102 Suppl 1():S37-48. PubMed ID: 18582796
    [Abstract] [Full Text] [Related]

  • 6. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Soler-Cataluña JJ, Rodriguez-Roisin R.
    COPD; 2010 Aug 15; 7(4):276-84. PubMed ID: 20673037
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.
    Decramer M, Gosselink R, Rutten-Van Mölken M, Buffels J, Van Schayck O, Gevenois PA, Pellegrino R, Derom E, De Backer W.
    Thorax; 2005 Apr 15; 60(4):335-42. PubMed ID: 15790991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quality of life: concept and definition.
    Kaplan RM, Ries AL.
    COPD; 2007 Sep 10; 4(3):263-71. PubMed ID: 17729071
    [Abstract] [Full Text] [Related]

  • 16. The role of patient-centered outcomes in defining the clinical course of chronic obstructive pulmonary disease. Introduction.
    Tashkin DP.
    Am J Med; 2006 Oct 10; 119(10 Suppl 1):1-3. PubMed ID: 16996893
    [No Abstract] [Full Text] [Related]

  • 17. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.
    Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK.
    J Pain Symptom Manage; 2009 Jul 10; 38(1):115-23. PubMed ID: 19232893
    [Abstract] [Full Text] [Related]

  • 18. Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort.
    Baughman P, Marott JL, Lange P, Andrew M, Hnizdo E.
    COPD; 2011 Apr 10; 8(2):103-13. PubMed ID: 21495838
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pharmacoeconomic profile of COPD patients with FEV1 50--60% predicted: pilot study on the impact of the extended indication of ICS/LABA.
    Dal Negro RW, Bonadiman L, Turati C, Turco P.
    Ther Adv Respir Dis; 2009 Apr 10; 3(2):51-8. PubMed ID: 19443518
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.